NeoGenomics Balance Sheet
NASDAQ: NEOHealth CarePrecision InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
NeoGenomics financial position
At the end of fiscal 2025, NeoGenomics reported total assets of $1.36 billion, down 17.0% from a year earlier against total liabilities of $523.3 million. Shareholders' equity stood at $836.6 million, or 61.5% of assets. The company held $159.6 million in cash and equivalents against $341.9 million of debt, a net debt position of $182.2 million.
The current ratio (current assets divided by current liabilities) was 4.26, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.41.
Summary generated from market data by MetaCap's automated system. Methodology
NeoGenomics balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 159.62M | 367.01M | 342.49M | 263.18M | 316.83M | 228.71M | 173.02M | 9.81M | 12.82M | 12.53M |
| Short-Term Investments | — | — | — | — | 198.56M | 67.55M | 0 | — | — | — |
| Receivables | 159.24M | 150.54M | 131.23M | 119.71M | 112.13M | 106.84M | 94.24M | 76.92M | 60.43M | 55.51M |
| Inventory | 28.57M | 26.75M | 24.16M | 24.28M | 23.39M | 29.53M | 14.40M | 8.65M | 7.47M | 6.25M |
| Total Current Assets | 376.29M | 596.02M | 596.81M | 605.29M | 681.51M | 448.73M | 290.74M | 103.67M | 85.88M | 78.83M |
| Property, Plant & Equipment | 84.83M | 94.10M | 92.01M | 102.50M | 109.47M | 85.87M | 64.19M | 60.89M | 36.50M | 34.04M |
| Goodwill | 524.34M | 522.77M | 522.77M | 522.77M | 527.12M | 211.08M | 198.60M | 197.89M | 147.02M | 147.02M |
| Intangible Assets | 286.53M | 339.68M | 373.13M | 408.26M | 442.32M | 120.65M | 126.64M | 140.03M | 74.17M | 77.06M |
| Total Assets | 1.36B | 1.64B | 1.68B | 1.74B | 1.87B | 988.33M | 709.51M | 505.01M | 344.45M | 337.12M |
| Accounts Payable | 23.09M | 21.61M | 20.33M | 20.51M | 17.92M | 24.96M | 19.57M | 17.78M | 10.45M | 16.78M |
| Short-Term Debt | 0 | 200.78M | 0 | 70.00K | 1.14M | 0 | 5.00M | 7.87M | 3.75M | 3.75M |
| Total Current Liabilities | 88.30M | 301.24M | 96.30M | 89.93M | 87.23M | 73.18M | 63.90M | 60.92M | 36.47M | 38.11M |
| Long-Term Debt | 341.86M | 340.33M | 538.20M | 535.32M | 532.55M | 169.09M | 95.03M | 92.88M | 91.13M | 91.95M |
| Total Liabilities | 523.27M | 735.70M | 739.69M | 742.01M | 761.50M | 294.04M | 202.10M | 184.57M | 139.88M | 150.52M |
| Shareholders' Equity | 836.56M | 902.34M | 941.54M | 998.02M | 1.11B | 694.29M | 507.41M | 320.44M | 171.96M | 162.32M |
| Retained Earnings | -433.81M | -325.78M | -247.06M | -159.09M | -14.84M | -7.18M | -11.36M | -19.36M | -58.42M | -52.46M |
| Total Debt | 341.86M | 541.11M | 538.20M | 535.39M | 533.69M | 169.09M | 100.03M | 100.75M | 94.88M | 95.70M |
| Net Cash (Debt) | -182.24M | -174.10M | -195.71M | -272.21M | -18.30M | 127.17M | 72.99M | -90.94M | -82.06M | -83.17M |
| Shares Outstanding | 128.99M | 128.15M | 127.37M | 126.91M | 124.11M | 112.08M | 104.78M | 94.47M | 80.46M | 78.57M |
This table shows 10 annual periods of NeoGenomics's balance sheet, from FY 2025 back to FY 2016, across 19 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow NEO's reporting calendar. What is a balance sheet?